A Comparison of 0.5% Loteprednol Etabonate Versus 1% Prednisolone Acetate Following Cataract Surgery

Intraocular Inflammation Clinical Trial

Official title:
A Randomized, Multicenter, Masked Evaluation of 0.5% Loteprednol Etabonate Versus 1% Prednisolone Acetate for the Treatment of Inflammation Following Cataract Surgery

Status Completed

Clinical Trial Summary

Patients are routinely given steroid eye drops following cataract surgery. This study will compare 2 approved drops:Loteprednol Etabonate versus Prednisolone Acetate Eye drops used following cataract surgery. Patients will be randomly assigned to one drop or the other, and evaluated for inflammation and intraocular pressure as part of the comparison. The study Doctor will be masked as to which drop the patient receives to avoid bias.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01384266
Study type	Observational
Source	Associated Eye Care, Minnesota
Contact
Status	Completed
Phase	N/A
Start date	May 2010
Completion date	November 2011

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05791695` - A Study of the Incidence of Intraocular Inflammation and Suspected Endophthalmitis Among Patients Treated With Aflibercept, Vial and Pre-filled Syringe, 2014-2022
Active, not recruiting	`NCT04914884` - Intraocular Fluid Detection in Endophthalmitis
Completed	`NCT05657158` - Analysis of Imaging Features From Patients Treated With Brolucizumab in the Post-marketing Setting With Reports of Retinal Vasculitis and/or Retinal Vascular Occlusion
Withdrawn	`NCT00958906` - Pilot Study for the Evaluation of Intravitreal Infliximab in the Treatment of Uveitic Macular Edema	Phase 1/Phase 2